Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,392 | 15,696 | 1,222 | 7,706 | 8,086 |
| Receivables | 733 | N/A | N/A | N/A | N/A |
| Other current assets | 978 | 0 | 0 | 0 | 0 |
| TOTAL | $19,103 | $15,696 | $1,222 | $7,706 | $8,086 |
| Non-Current Assets | |||||
| PPE Net | 92 | 30 | 30 | 20 | 21 |
| Intangibles | 3,584 | 4,255 | 4,926 | 5,597 | 6,268 |
| Other Non-Current Assets | 3,405 | 27 | 27 | 27 | 27 |
| TOTAL | $7,081 | $4,312 | $4,983 | $5,644 | $6,317 |
| Total Assets | $26,184 | $20,008 | $6,205 | $13,350 | $14,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 441 | 349 | 243 | 101 | 419 |
| Accrued Expenses | 91 | 61 | 61 | 71 | 891 |
| TOTAL | $848 | $513 | $511 | $263 | $1,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 147 | 12,867 | 1,300 | 3,068 | 2,353 |
| TOTAL | $147 | $12,867 | $1,300 | $3,068 | $2,353 |
| Total Liabilities | $994 | $13,380 | $1,811 | $3,330 | $3,703 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 185,171 | 172,450 | 122,058 | N/A | N/A |
| Common Shares | 185 | 160 | 118 | 111 | 91 |
| Retained earnings | -156,294 | -146,051 | -118,353 | -105,785 | -86,350 |
| TOTAL | $25,190 | $6,629 | $4,394 | $10,020 | $10,700 |
| Total Liabilities And Equity | $26,184 | $20,008 | $6,205 | $13,350 | $14,403 |